# Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516

> **NCT00818714** · PHASE1 · WITHDRAWN · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- Non-Small Cell Lung Cancer (NSCLC)

## Interventions

- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT00818714
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-01
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There was no patient accrual nor study activity due to inability to fund PFTs.
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00818714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00818714, "Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00818714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*